OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes

Introduction: Increasing insulin prices have led to a renewed debate to determine if Rapid Acting Insulin (RAI) analogs offer an advantage over less expensive Regular Human Insulins (RHI). The steep increase in the cost of RAI has led to rationing of insulin or the total discontinuance of therapy by...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Endocr Soc
Main Authors: Mora, Pablo, Sutton, David R, Gore, Ashwini, Baliga, Bantwal S, Goldfaden, PharmD, Rebecca, Nikkel, Carla, Sink II, John, Adams-Huet, Beverley
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Diabetes Mellitus and Glucose Metabolism
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208657/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.448
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki